BRUSSEL'S UROLOGICAL SOCIETY
ActiveSummary
BRUSSEL'S UROLOGICAL SOCIETY has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €27k and a net result of €-4k. Equity is shrinking by ~23.9% per year across the filed fiscal years. Its solvency ranks better than 83% of 637 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
81
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability69▲+69
Solvency100▲+10
Growth38▲+16
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2k at 30 days acceptable
Liquidity ample (current ratio 2.9 against 1.55 in 2024; short-term debt: 16.1% and cash: 6.2% of total assets), and 16.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
83.9%
Return on assets
-12.1%
Age of the figures
9 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year €-4k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-03-2026, 132 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
132 d early
2024
145 d early
2023
170 d early
2022
136 d early
2021
109 d early
2020
170 d early
2019
193 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€24k▼ 16.2%
2024 · €28k
2021: €66k
2024: €28k
2021 → 2025
EBIT margin
-12.6%▲ 46.4pp
2024 · -59.0%
2021: -10.4%
2024: -59.0%
2021 → 2025
Net result
€-4k▲ 76.9%
2024 · €-17k
2018: €-8k
2019: €-26k
2020: €-25k
2021: €-5k
2022: €9k
2023: €-6k
2024: €-17k
2018 → 2025
Working capital
€10k▲ 37.8%
2024 · €7k
2018: €112k
2019: €105k
2020: €90k
2021: €31k
2022: €19k
2023: €23k
2024: €7k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€66k-€28k€24k▼ 16.2%
Equity€46k-€54k▲ 19.0%€48k▼ 11.7%€31k▼ 35.3%€27k▼ 12.6%
Operating result€-7k-€11k€-6k€-17k▼ 193%€-3k▲ 82.1%
Net result€-5k-€9k€-6k€-17k▼ 191%€-4k▲ 76.9%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €3k in 2025 against €17k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €32k
Fixed assets
€17k ▼ 37.1%
Current assets
€15k ▼ 25.2%
Equity and liabilities €32k
Equity
€27k ▼ 12.6%
Debt
€5k ▼ 68.5%
Debt's share of the balance-sheet total falls from 34.8% to 16.1%. Equity and debt are lower.
Key figures and ratios
EBITDA
€7k▲
2024 · €-6k
Cash flow
€6k▲
2024 · €-6k
Current ratio
2.90▲
2024 · 1.55
Debt to equity
0.19▼
2024 · 0.53
ROE
-14.4%▲
2024 · -54.6%
ROA
-12.1%▲
2024 · -35.6%
Interest coverage
20.60▲
2024 · -8.30
Debt ≤ 1 year
€5k▼
2024 · €13k
Income taxes
€790▲
2024 · €-310
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet
Code20242025
Assets
Total assets20/58€48k€32k▼
Fixed assets21/28€27k€17k▼
Tangible fixed assets22/27€27k€17k▼
Furniture and vehicles24€27k€17k▼
Financial fixed assets28€226€226=
Current assets29/58€20k€15k▼
Current investments50/53€20k€13k▼
Cash at bank and in hand54/58-€2k
Equity and liabilities
Total equity and liabilities10/49€48k€32k▼
Equity10/15€31k€27k▼
Contributions10/11€6k€6k=
Capital10€6k€6k=
Issued capital100€19k€19k=
Uncalled capital101€12k€12k=
Reserves13€2k€2k=
Non-distributable reserves130/1€2k€2k=
Legal reserve130-€2k
Reserves not available under the articles1311€2k-
Profit (loss) carried forward14€23k€19k▼
Amounts payable17/49€17k€5k▼
Amounts payable after more than one year17€4k-
Financial debts170/4€4k-
Amounts payable within one year42/48€13k€5k▼
Current portion of amounts payable after more than one year42€7k€4k▼
Trade debts44€2k€28▼
Suppliers440/4€2k€28▼
Other amounts payable47/48€4k€2k▼
Income statement
Code20242025
Turnover70€28k€24k▼
Non-recurring operating income76A-€415k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11k€10k▼
Gross operating margin9900€-6k€7k▲
Operating profit (loss)9901€-17k€-3k▲
Financial income75/76B€279€236▼
Recurring financial income75€279€236▼
Financial charges65/66B€735€347▼
Recurring financial charges65€735€347▼
Non-recurring financial charges66B€735-
Profit (loss) for the period before taxes9903€-17k€-3k▲
Income taxes67/77€-310€790▲
Profit (loss) for the period9904€-17k€-4k▲
Profit (loss) for the period to be appropriated9905€-17k€-4k▲
Appropriation of the result
Profit (loss) to be appropriated9906€23k€19k▼
Profit (loss) brought forward from the previous period14P€40k€23k▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
21-03
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
08-03
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
12-02
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Liquidity doublescurrent ratio 3.22
Current ratio from 1.56 to 3.22; short-term debt falls from €35k to €10k.
17-03
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Back to profitnet €9k
Net result €9k after 4 loss-making years.
13-04
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
11-02
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
09-02
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 193 days late
2019
31-12
Financial
Weakest financial yearnet €-26k
Net result drops to €-26k, the lowest in the series; recovery starts the following year.
28-03
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
20-03
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
20-03
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 2 establishment units since 1998
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hippolyte Boulengerlaan 361180 UkkelGround area
1.4 ha
Building footprint
2,989 m²
Volume, LiDAR
91,559 m³
3 parcels, Brussels, Flanders · tallest building 51.4 m, ±13 floors. Linked by address, not a title deed.
2 establishment units
Froissartstraat 38, 1040 Etterbeek
since 19982.229.691.092
Dwersbos 10, 1630 Linkebeek
since 20002.229.691.488
3 parcels
Flanders
1
(33.3%)
Brussels
2
(66.7%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21614H0003/00A008 | Brussels | 8,765 m² | 1 · 281 m² | 12.4 m · 3 fl. |
| 21005A0200/00P003 | Brussels | 3,468 m² | 1 · 2,462 m² | 51.4 m · 13 fl. |
| 22003A0278/00M000 | Flanders | 1,573 m² | 1 · 246 m² | 10.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LCoMed
BE 0795.362.683
Schaarbeek · Eq €27,048
Dr. Remco van Hijningen
BE 0734.545.366
Turnhout · Eq €27,039
YUNUS DEMIR
BE 1012.473.528
Sint-Pieters-Leeuw · Eq €27,036
JACQUES RENARD MEDICAL
BE 1001.227.466
Oreye · Eq €27,149
SWINNEN KRISTOF DR.
BE 0755.609.016
Hechtel-Eksel · Eq €27,151
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 3,733 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded05-01-1994
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 32 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.